Reco Medical Limited

Reco Medical LTD is an ISO 13485-certified spinout company from Imperial College London. The core patented sensing technology has been developed by the team, supported by the Department of Health and Social Care and the Wellcome Trust through a £5 Million research grant. With the support from highly competitive grants from InnovateUK- a Smart grant in 2020 and an Biomedical Catalyst Award in 2023- Reco fabricated sensors in a scalable setting, built a Quality Management System according to ISO 13485 and successfully completed an acute animal study. Reco is currently aiming to complete pre-clinical tests and launch the ICP-SENSE® system (pending regulatory approval), revolutionizing healthcare for both patients and healthcare professionals. Reco Medical is pioneering cutting-edge technological advancements, tackling the most pressing health issues and broadening horizons for all patients.